Breast cancer hormonal therapy

Details Breast cancer hormonal therapy Breast cancer hormonal therapy

A - Human Necessities

61

K

A61K 31/565 (2006.01) A61K 31/566 (2006.01)

Patent

CA 2401041

Exemestane is disclosed for use in the first-line treatment of metastatic, advanced hormone-dependent breast cancer, particularly in post-menopausal woman.

L'invention se rapporte à l'utilisation d'exemestane pour le traitement de première intention du cancer du sein hormonodépendant, avancé et métastatique, notamment chez la femme post-ménopausique.

Affiliated with

Also associated with

Rating

Breast cancer hormonal therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Breast cancer hormonal therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breast cancer hormonal therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1870700